Xeris Pharmaceuticals | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Adcock Ingram Holdings ZAR 89.42M 17.72M 2024-06
Celltrion KRW 972.66B 68.24B 2024-09
Cspc Pharmaceutical 8.37B 3.64B 2024-06
Dianthus Therapeutics USD 33.67M 280.5M 2024-09
Ecofibre AUD 6.74M 4.89M 2024-06
Eli Lilly USD 3.27B 100.6M 2024-12
Kangmei Pharma CNY 773.51M 28.83M 2024-09
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Laboratorios Farma EUR 44.58M 31.49M 2024-06
Malin Corporation EUR 35.7M 6.4M 2024-06
Medical Developments International AUD 9.74M 5.96M 2024-06
Neuren Pharmaceuticals AUD 3.15M 582K 2024-12
Organigram Holdings 79.26M 7.45M 2024-06
Pacira USD 276.77M 30.81M 2024-12
Perrigo USD 558.8M 904.7M 2024-12
Pharma Mar EUR 63.24M 28.44M 2024-12
Qiagen NV USD 663.56M 309.42M 2024-12
Sartorius EUR 579.2M 12M 2024-09
Sino Biopharmaceutical CNY 8.55B 902.41M 2024-06
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
Tilray USD 189.7M 15.49M 2024-11
Zz Pientze Pharmaceu 3.27B 895.19M 2024-09



Xeris Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.